A combination of two drugs was capable of suppressing tumors in a non-conventional manner. Instead of inhibiting tumor cell division, as the most widely used medications do, the strategy consisted of hyperactivating oncogenic signaling by these cells to the point where they became stressed.
No Change in Huntington’s Motor Symptoms With Investigational Drug
Investigational laquinimod did not change motor symptoms of Huntington’s disease after 1 year but did significantly reduce caudate volume loss compared with placebo, the phase
February 9, 2024